Home > > > Report Detail

Global and China Breakthrough Therapy (BT) Designation Market 2020 by Company, Type and Application, Forecast to 2025

Publisher Name :
Date: 29-Feb-2020
No. of pages: 132

Market Overview

The global Breakthrough Therapy (BT) Designation market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.7% in the forecast period of 2020 to 2025 and will expected to reach USD 69830 million by 2025, from USD 51990 million in 2019.

The Breakthrough Therapy (BT) Designation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Breakthrough Therapy (BT) Designation market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Breakthrough Therapy (BT) Designation market has been segmented into Oncology, Infectious Diseases, Rare Diseases, Autoimmune Diseases, Pulmonary Diseases, Neurological Disorders, Others, etc.

Breakdown by Application, Breakthrough Therapy (BT) Designation has been segmented into Hospital, Clinic, Research Institute, Laboratories, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Breakthrough Therapy (BT) Designation market presented in the report. This section sheds light on the sales growth of different regional and country-level Breakthrough Therapy (BT) Designation markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Breakthrough Therapy (BT) Designation market.

For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Breakthrough Therapy (BT) Designation Market Share Analysis

Breakthrough Therapy (BT) Designation competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Breakthrough Therapy (BT) Designation revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Breakthrough Therapy (BT) Designation revenue and market share for each player covered in this report.

The major players covered in Breakthrough Therapy (BT) Designation are: Roche, Sanofi, Janssen, Abbvie, Gilead, Novartis International AG, Acadia, Eli Lilly, BMS, Regeneron, Vertex, Jazz Pharmaceuticals, Boehringer Ingelheim, Eisai, Alexion, GlaxoSmithKline, Amgen, Exelixis, Merck, AstraZeneca, Takeda, Pfizer, etc. Among other players domestic and global, Breakthrough Therapy (BT) Designation market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market segment by players, this report covers

- Roche

- Sanofi

- Janssen

- Abbvie

- Gilead

- Novartis International AG

- Acadia

- Eli Lilly

- BMS

- Regeneron

- Vertex

- Jazz Pharmaceuticals

- Boehringer Ingelheim

- Eisai

- Alexion

- GlaxoSmithKline

- Amgen

- Exelixis

- Merck

- AstraZeneca

- Takeda

- Pfizer

Market segment by regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

- South America (Brazil, Argentina)

- MENA (Saudi Arabia, UAE, Turkey and South Africa)

Market segment by Type, covers:

- Oncology

- Infectious Diseases

- Rare Diseases

- Autoimmune Diseases

- Pulmonary Diseases

- Neurological Disorders

- Others

Market segment by Application, can be divided into

- Hospital

- Clinic

- Research Institute

- Laboratories

Global and China Breakthrough Therapy (BT) Designation Market 2020 by Company, Type and Application, Forecast to 2025

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Breakthrough Therapy (BT) Designation
1.2 Classification of Breakthrough Therapy (BT) Designation by Type
1.2.1 Overview: Global Breakthrough Therapy (BT) Designation Revenue by Type: 2015 Versus 2019 Versus 2025
1.2.2 Global Breakthrough Therapy (BT) Designation Revenue Market Share by Type in 2019
1.2.3 Oncology
1.2.4 Infectious Diseases
1.2.5 Rare Diseases
1.2.6 Autoimmune Diseases
1.2.7 Pulmonary Diseases
1.2.8 Neurological Disorders
1.2.9 Others
1.3 Global Breakthrough Therapy (BT) Designation Market by Application
1.3.1 Overview: Global Breakthrough Therapy (BT) Designation Revenue by Application: 2015 Versus 2019 Versus 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Laboratories
1.4 Global Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)
1.5 Global Breakthrough Therapy (BT) Designation Market Size by Regions: 2015 VS 2019 VS 2025
1.6 Global Breakthrough Therapy (BT) Designation Market Size by Regions (2015-2020)
1.7 Global Breakthrough Therapy (BT) Designation Market Size and Forecast by Regions (2020-2025)
1.7.1 North America Breakthrough Therapy (BT) Designation Status and Prospect (2015-2025)
1.7.2 Europe Breakthrough Therapy (BT) Designation Status and Prospect (2015-2025)
1.7.3 Asia Breakthrough Therapy (BT) Designation Status and Prospect (2015-2025)
1.7.4 South America Breakthrough Therapy (BT) Designation Status and Prospect (2015-2025)
1.7.5 Middle East & Africa Breakthrough Therapy (BT) Designation Status and Prospect (2015-2025)

2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.3 Janssen
2.3.1 Janssen Details
2.3.2 Janssen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Janssen SWOT Analysis
2.3.4 Janssen Product and Services
2.3.5 Janssen Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbvie
2.4.1 Abbvie Details
2.4.2 Abbvie Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbvie SWOT Analysis
2.4.4 Abbvie Product and Services
2.4.5 Abbvie Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.5 Gilead
2.5.1 Gilead Details
2.5.2 Gilead Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Gilead SWOT Analysis
2.5.4 Gilead Product and Services
2.5.5 Gilead Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis International AG
2.6.1 Novartis International AG Details
2.6.2 Novartis International AG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis International AG SWOT Analysis
2.6.4 Novartis International AG Product and Services
2.6.5 Novartis International AG Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.7 Acadia
2.7.1 Acadia Details
2.7.2 Acadia Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Acadia SWOT Analysis
2.7.4 Acadia Product and Services
2.7.5 Acadia Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly SWOT Analysis
2.8.4 Eli Lilly Product and Services
2.8.5 Eli Lilly Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.9 BMS
2.9.1 BMS Details
2.9.2 BMS Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 BMS SWOT Analysis
2.9.4 BMS Product and Services
2.9.5 BMS Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.10 Regeneron
2.10.1 Regeneron Details
2.10.2 Regeneron Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Regeneron SWOT Analysis
2.10.4 Regeneron Product and Services
2.10.5 Regeneron Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.11 Vertex
2.11.1 Vertex Details
2.11.2 Vertex Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Vertex SWOT Analysis
2.11.4 Vertex Product and Services
2.11.5 Vertex Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.12 Jazz Pharmaceuticals
2.12.1 Jazz Pharmaceuticals Details
2.12.2 Jazz Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Jazz Pharmaceuticals SWOT Analysis
2.12.4 Jazz Pharmaceuticals Product and Services
2.12.5 Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.13 Boehringer Ingelheim
2.13.1 Boehringer Ingelheim Details
2.13.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Boehringer Ingelheim SWOT Analysis
2.13.4 Boehringer Ingelheim Product and Services
2.13.5 Boehringer Ingelheim Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.14 Eisai
2.14.1 Eisai Details
2.14.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Eisai SWOT Analysis
2.14.4 Eisai Product and Services
2.14.5 Eisai Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.15 Alexion
2.15.1 Alexion Details
2.15.2 Alexion Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Alexion SWOT Analysis
2.15.4 Alexion Product and Services
2.15.5 Alexion Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.16 GlaxoSmithKline
2.16.1 GlaxoSmithKline Details
2.16.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 GlaxoSmithKline SWOT Analysis
2.16.4 GlaxoSmithKline Product and Services
2.16.5 GlaxoSmithKline Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.17 Amgen
2.17.1 Amgen Details
2.17.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Amgen SWOT Analysis
2.17.4 Amgen Product and Services
2.17.5 Amgen Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.18 Exelixis
2.18.1 Exelixis Details
2.18.2 Exelixis Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Exelixis SWOT Analysis
2.18.4 Exelixis Product and Services
2.18.3 Exelixis Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.19 Merck
2.19.1 Merck Details
2.19.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Merck SWOT Analysis
2.19.4 Merck Product and Services
2.19.5 Merck Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.20 AstraZeneca
2.20.1 AstraZeneca Details
2.20.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 AstraZeneca SWOT Analysis
2.20.4 AstraZeneca Product and Services
2.20.5 AstraZeneca Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.21 Takeda
2.21.1 Takeda Details
2.21.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Takeda SWOT Analysis
2.21.4 Takeda Product and Services
2.21.5 Takeda Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.22 Pfizer
2.22.1 Pfizer Details
2.22.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 Pfizer SWOT Analysis
2.22.4 Pfizer Product and Services
2.22.5 Pfizer Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players
3.1 Global Breakthrough Therapy (BT) Designation Market Size by Players (2015-2020)
3.2 China Breakthrough Therapy (BT) Designation Market Size by Players (2015-2020)
3.3 Market Concentration Rate
3.3.1 Top 5 Breakthrough Therapy (BT) Designation Players Market Share
3.3.2 Top 10 Breakthrough Therapy (BT) Designation Players Market Share

4 North America Market Size and Forecast by Countries
4.1 North America Breakthrough Therapy (BT) Designation Market Size by Countries (2015-2020)
4.2 North America Breakthrough Therapy (BT) Designation Market Size and Forecast by Countries (2015-2026)
4.3 United States Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)
4.4 Canada Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)
4.5 Mexico Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries
5.1 Europe Breakthrough Therapy (BT) Designation Market Size by Countries (2015-2020)
5.2 Europe Breakthrough Therapy (BT) Designation Market Size and Forecast by Countries (2015-2026)
5.3 Germany Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)
5.4 France Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)
5.5 UK Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)
5.6 Russia Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)
5.7 Italy Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries
6.1 Asia-Pacific Breakthrough Therapy (BT) Designation Market Size by Regions (2015-2020)
6.2 Asia-Pacific Breakthrough Therapy (BT) Designation Market Size and Forecast by Regions (2015-2026)
6.3 China Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)
6.4 Japan Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)
6.5 Korea Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)
6.6 India Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)
6.7 Southeast Asia Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries
7.1 South America Breakthrough Therapy (BT) Designation Market Size by Countries (2015-2020)
7.2 South America Breakthrough Therapy (BT) Designation Market Size and Forecast by Countries (2015-2026)
7.3 Brazil Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)
7.4 Argentina Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries
8.1 Middle East & Africa Breakthrough Therapy (BT) Designation Revenue by Regions (2015-2020)
8.2 Middle East & Africa Breakthrough Therapy (BT) Designation Market Size and Forecast by Countries (2015-2026)
8.3 Saudi Arabia Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)
8.4 UAE Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)
8.5 Egypt Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)
8.6 South Africa Breakthrough Therapy (BT) Designation Market Size and Forecast (2015-2025)

9 Market Size Segment by Type
9.1 Global Breakthrough Therapy (BT) Designation Market Size and Forecast by Type (2015-2025)
9.1.1 Global Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020)
9.1.2 Global Breakthrough Therapy (BT) Designation Market Size Forecast by Type (2020-2025)
9.2 China Breakthrough Therapy (BT) Designation Market Size and Forecast by Type (2015-2025)
9.2.1 China Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020)
9.2.2 China Breakthrough Therapy (BT) Designation Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application
10.1 Global Breakthrough Therapy (BT) Designation Market Size and Forecast by Application (2015-2025)
10.1.1 Global Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)
10.1.2 Global Breakthrough Therapy (BT) Designation Market Size Forecast by Application (2020-2025)
10.2 China Breakthrough Therapy (BT) Designation Market Size and Forecast by Application (2015-2025)
10.2.1 China Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)
10.2.2 China Breakthrough Therapy (BT) Designation Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Data Source
12.3 Disclaimer
12.4 About US

List of Tables

Table 1. Global Breakthrough Therapy (BT) Designation Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025
Table 2. Breakdown of Breakthrough Therapy (BT) Designation by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Breakthrough Therapy (BT) Designation Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025
Table 4. Global Market Breakthrough Therapy (BT) Designation Market Size (USD Million) Comparison by Regions (2020-2025)
Table 5. Global Breakthrough Therapy (BT) Designation Revenue (USD Million) by Regions (2015-2020)
Table 6. Global Breakthrough Therapy (BT) Designation Revenue Share by Regions (2015-2020)
Table 7. Global Breakthrough Therapy (BT) Designation Revenue (USD Million) by Regions (2020-2025)
Table 8. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Regions (2020-2025)
Table 9. Roche Corporate Information, Location and Competitors
Table 10. Roche Major Business
Table 11. Roche Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 12. Roche SWOT Analysis
Table 13. Roche Breakthrough Therapy (BT) Designation Product and Solutions
Table 14. Roche Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 15. Sanofi Corporate Information, Location and Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2018-2019)
Table 18. Sanofi SWOT Analysis
Table 19. Sanofi Breakthrough Therapy (BT) Designation Product and Solutions
Table 20. Sanofi Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 21. Janssen Corporate Information, Location and Competitors
Table 22. Janssen Major Business
Table 23. Janssen Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 24. Janssen SWOT Analysis
Table 25. Janssen Breakthrough Therapy (BT) Designation Product and Solutions
Table 26. Janssen Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 27. Abbvie Corporate Information, Location and Competitors
Table 28. Abbvie Major Business
Table 29. Abbvie Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 30. Abbvie SWOT Analysis
Table 31. Abbvie Breakthrough Therapy (BT) Designation Product and Solutions
Table 32. Abbvie Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 33. Gilead Corporate Information, Location and Competitors
Table 34. Gilead Major Business
Table 35. Gilead Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 36. Gilead SWOT Analysis
Table 37. Gilead Breakthrough Therapy (BT) Designation Product and Solutions
Table 38. Gilead Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 39. Novartis International AG Corporate Information, Location and Competitors
Table 40. Novartis International AG Major Business
Table 41. Novartis International AG Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 42. Novartis International AG SWOT Analysis
Table 43. Novartis International AG Breakthrough Therapy (BT) Designation Product and Solutions
Table 44. Novartis International AG Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 45. Acadia Corporate Information, Location and Competitors
Table 46. Acadia Major Business
Table 47. Acadia Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 48. Acadia SWOT Analysis
Table 49. Acadia Breakthrough Therapy (BT) Designation Product and Solutions
Table 50. Acadia Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 51. Eli Lilly Corporate Information, Location and Competitors
Table 52. Eli Lilly Major Business
Table 53. Eli Lilly Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 54. Eli Lilly SWOT Analysis
Table 55. Eli Lilly Breakthrough Therapy (BT) Designation Product and Solutions
Table 56. Eli Lilly Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 57. BMS Corporate Information, Location and Competitors
Table 58. BMS Major Business
Table 59. BMS Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 60. BMS SWOT Analysis
Table 61. BMS Breakthrough Therapy (BT) Designation Product and Solutions
Table 62. BMS Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 63. Regeneron Corporate Information, Location and Competitors
Table 64. Regeneron Major Business
Table 65. Regeneron Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 66. Regeneron SWOT Analysis
Table 67. Regeneron Breakthrough Therapy (BT) Designation Product and Solutions
Table 68. Regeneron Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 69. Vertex Corporate Information, Location and Competitors
Table 70. Vertex Major Business
Table 71. Vertex Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 72. Vertex SWOT Analysis
Table 73. Vertex Breakthrough Therapy (BT) Designation Product and Solutions
Table 74. Vertex Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 75. Jazz Pharmaceuticals Corporate Information, Location and Competitors
Table 76. Jazz Pharmaceuticals Major Business
Table 77. Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 78. Jazz Pharmaceuticals SWOT Analysis
Table 79. Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Product and Solutions
Table 80. Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 81. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 82. Boehringer Ingelheim Major Business
Table 83. Boehringer Ingelheim Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 84. Boehringer Ingelheim SWOT Analysis
Table 85. Boehringer Ingelheim Breakthrough Therapy (BT) Designation Product and Solutions
Table 86. Boehringer Ingelheim Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 87. Eisai Corporate Information, Location and Competitors
Table 88. Eisai Major Business
Table 89. Eisai Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 90. Eisai SWOT Analysis
Table 91. Eisai Breakthrough Therapy (BT) Designation Product and Solutions
Table 92. Eisai Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 93. Alexion Corporate Information, Location and Competitors
Table 94. Alexion Major Business
Table 95. Alexion Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 96. Alexion SWOT Analysis
Table 97. Alexion Breakthrough Therapy (BT) Designation Product and Solutions
Table 98. Alexion Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 99. GlaxoSmithKline Corporate Information, Location and Competitors
Table 100. GlaxoSmithKline Major Business
Table 101. GlaxoSmithKline Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 102. GlaxoSmithKline SWOT Analysis
Table 103. GlaxoSmithKline Breakthrough Therapy (BT) Designation Product and Solutions
Table 104. GlaxoSmithKline Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 105. Amgen Corporate Information, Location and Competitors
Table 106. Amgen Major Business
Table 107. Amgen Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 108. Amgen SWOT Analysis
Table 109. Amgen Breakthrough Therapy (BT) Designation Product and Solutions
Table 110. Amgen Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 111. Exelixis Breakthrough Therapy (BT) Designation Type and Application
Table 112. Exelixis Major Business
Table 113. Exelixis Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 114. Exelixis SWOT Analysis
Table 115. Exelixis Breakthrough Therapy (BT) Designation Product and Solutions
Table 116. Exelixis Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 117. Merck Corporate Information, Location and Competitors
Table 118. Merck Major Business
Table 119. Merck Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 120. Merck SWOT Analysis
Table 121. Merck Breakthrough Therapy (BT) Designation Product and Solutions
Table 122. Merck Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 123. AstraZeneca Corporate Information, Location and Competitors
Table 124. AstraZeneca Major Business
Table 125. AstraZeneca Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 126. AstraZeneca SWOT Analysis
Table 127. AstraZeneca Breakthrough Therapy (BT) Designation Product and Solutions
Table 128. AstraZeneca Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 129. Takeda Corporate Information, Location and Competitors
Table 130. Takeda Major Business
Table 131. Takeda Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 132. Takeda SWOT Analysis
Table 133. Takeda Breakthrough Therapy (BT) Designation Product and Solutions
Table 134. Takeda Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 135. Pfizer Corporate Information, Location and Competitors
Table 136. Pfizer Major Business
Table 137. Pfizer Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 138. Pfizer SWOT Analysis
Table 139. Pfizer Breakthrough Therapy (BT) Designation Product and Solutions
Table 140. Pfizer Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 141. Global Breakthrough Therapy (BT) Designation Revenue (USD Million) by Players (2015-2020)
Table 142. Global Breakthrough Therapy (BT) Designation Revenue Share by Players (2015-2020)
Table 143. Key Players Breakthrough Therapy (BT) Designation Revenue (USD Million) in China (2015-2020)
Table 144. Key Players Breakthrough Therapy (BT) Designation Revenue Share in China (2015-2020)
Table 145. North America Breakthrough Therapy (BT) Designation Revenue (USD Million) by Countries (2015-2020)
Table 146. North America Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)
Table 147. North America Breakthrough Therapy (BT) Designation Revenue (USD Million) by Countries (2020-2026)
Table 148. North America Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2020-2026)
Table 149. Europe Breakthrough Therapy (BT) Designation Revenue (USD Million) by Countries (2015-2020)
Table 150. Europe Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)
Table 151. Europe Breakthrough Therapy (BT) Designation Revenue (USD Million) by Countries (2020-2026)
Table 152. Europe Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2020-2026)
Table 153. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue (USD Million) by Countries (2015-2020)
Table 154. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)
Table 155. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue (USD Million) by Countries (2020-2026)
Table 156. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2020-2026)
Table 157. South America Breakthrough Therapy (BT) Designation Revenue (USD Million) by Countries (2015-2020)
Table 158. South America Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)
Table 159. South America Breakthrough Therapy (BT) Designation Revenue (USD Million) by Countries (2020-2026)
Table 160. South America Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2020-2026)
Table 161. Middle East & Africa Breakthrough Therapy (BT) Designation Revenue (USD Million) by Countries (2015-2020)
Table 162. Middle East & Africa Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)
Table 163. Middle East & Africa Breakthrough Therapy (BT) Designation Revenue (USD Million) by Countries (2020-2026)
Table 164. Middle East & Africa Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2020-2026)
Table 165. Global Breakthrough Therapy (BT) Designation Revenue (USD Million) by Type (2015-2020)
Table 166. Global Breakthrough Therapy (BT) Designation Revenue Share by Type (2015-2020)
Table 167. Global Breakthrough Therapy (BT) Designation Revenue Forecast by Type (2020-2025)
Table 168. Global Breakthrough Therapy (BT) Designation Market Share Forecast by Type (2020-2025)
Table 169. China Breakthrough Therapy (BT) Designation Revenue (USD Million) by Type (2015-2020)
Table 170. China Breakthrough Therapy (BT) Designation Revenue Share by Type (2015-2020)
Table 171. China Breakthrough Therapy (BT) Designation Revenue Forecast by Type (2020-2025)
Table 172. China Breakthrough Therapy (BT) Designation Market Share Forecast by Type (2020-2025)
Table 173. Global Breakthrough Therapy (BT) Designation Revenue (USD Million) by Application (2015-2020)
Table 174. Global Breakthrough Therapy (BT) Designation Revenue Share by Application (2015-2020)
Table 175. Global Breakthrough Therapy (BT) Designation Revenue Forecast by Application (2020-2025)
Table 176. Global Breakthrough Therapy (BT) Designation Market Share Forecast by Application (2020-2025)
Table 177. China Breakthrough Therapy (BT) Designation Revenue (USD Million) by Application (2015-2020)
Table 178. China Breakthrough Therapy (BT) Designation Revenue Share by Application (2015-2020)
Table 179. China Breakthrough Therapy (BT) Designation Revenue Forecast by Application (2020-2025)
Table 180. China Breakthrough Therapy (BT) Designation Market Share Forecast by Application (2020-2025)

List of Figures

Figure 1. Breakthrough Therapy (BT) Designation Picture
Figure 2. Global Breakthrough Therapy (BT) Designation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Type in 2019
Figure 4. Oncology Picture
Figure 5. Infectious Diseases Picture
Figure 6. Rare Diseases Picture
Figure 7. Autoimmune Diseases Picture
Figure 8. Pulmonary Diseases Picture
Figure 9. Neurological Disorders Picture
Figure 10. Others Picture
Figure 11. Breakthrough Therapy (BT) Designation Revenue Market Share by Application in 2019
Figure 12. Hospital Picture
Figure 13. Clinic Picture
Figure 14. Research Institute Picture
Figure 15. Laboratories Picture
Figure 16. Global Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2025) (USD Million)
Figure 17. Global Breakthrough Therapy (BT) Designation Market Size Share by Regions (2015-2025)
Figure 18. Global Breakthrough Therapy (BT) Designation Market Size Share by Regions in 2019
Figure 19. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Regions (2020-2025)
Figure 20. North America Breakthrough Therapy (BT) Designation Revenue (USD Million) and Growth Rate (2015-2025)
Figure 21. Europe Breakthrough Therapy (BT) Designation Revenue (USD Million) and Growth Rate (2015-2025)
Figure 22. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue (USD Million) and Growth Rate (2015-2025)
Figure 23. South America Breakthrough Therapy (BT) Designation Revenue (USD Million) and Growth Rate (2015-2025)
Figure 24. Middle East & Africa Breakthrough Therapy (BT) Designation Revenue (USD Million) and Growth Rate (2015-2025)
Figure 25. Global Breakthrough Therapy (BT) Designation Revenue Share by Players in 2019
Figure 26. Global Top 5 Players Breakthrough Therapy (BT) Designation Revenue Market Share in 2019
Figure 27. Top 10 Players Breakthrough Therapy (BT) Designation Revenue Market Share in Global Market in 2019
Figure 28. Global Breakthrough Therapy (BT) Designation Market Size (USD Million) by Type (2015-2025)
Figure 29. Global Breakthrough Therapy (BT) Designation Market Size Share by Application (2015-2025)
Figure 30. North America Breakthrough Therapy (BT) Designation Market Size Share by Countries (2015-2025)
Figure 31. North America Breakthrough Therapy (BT) Designation Market Size Share by Countries in 2019
Figure 32. United States Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)
Figure 33. Canada Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)
Figure 34. Mexico Breakthrough Therapy (BT) Designation Market Size (USD Million) and Forecast (2015-2025)
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs